GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (HKSE:00241) » Definitions » ROCE %

Alibaba Health Information Technology (HKSE:00241) ROCE % : 5.96% (As of Sep. 2023)


View and export this data going back to 1972. Start your Free Trial

What is Alibaba Health Information Technology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Alibaba Health Information Technology's annualized ROCE % for the quarter that ended in Sep. 2023 was 5.96%.


Alibaba Health Information Technology ROCE % Historical Data

The historical data trend for Alibaba Health Information Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alibaba Health Information Technology ROCE % Chart

Alibaba Health Information Technology Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.21 0.76 4.20 -1.76 3.61

Alibaba Health Information Technology Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.22 -0.28 2.29 5.04 5.96

Alibaba Health Information Technology ROCE % Calculation

Alibaba Health Information Technology's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2023 )  (A: Mar. 2022 )(A: Mar. 2023 )
=634.223/( ( (23675.75 - 5945.62) + (23631.661 - 6193.221) )/ 2 )
=634.223/( (17730.13+17438.44)/ 2 )
=634.223/17584.285
=3.61 %

Alibaba Health Information Technology's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2023 )  (Q: Mar. 2023 )(Q: Sep. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2023 )  (Q: Mar. 2023 )(Q: Sep. 2023 )
=1037.788/( ( (23631.661 - 6193.221) + (22998.481 - 5588.737) )/ 2 )
=1037.788/( ( 17438.44 + 17409.744 )/ 2 )
=1037.788/17424.092
=5.96 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alibaba Health Information Technology  (HKSE:00241) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Alibaba Health Information Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alibaba Health Information Technology (HKSE:00241) Business Description

Traded in Other Exchanges
Address
Guanghua Road, 65/F, CITIC Tower, Building 1, No.10, Jianwai Subdistrict, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Alibaba Health Information Technology (HKSE:00241) Headlines

No Headlines